The Net Margin of Alnylam Pharmaceuticals Inc (ALNY) is -12.37%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | -12.37% |
| 2023-12-31 | -24.08% |
| 2022-12-31 | -109.04% |
| 2021-12-31 | -101.01% |
| 2020-12-31 | -174.13% |
| 2019-12-31 | -403.14% |
| 2018-12-31 | -1016.69% |
| 2017-12-31 | -546.05% |
| 2016-12-31 | -868.86% |
| 2015-12-31 | -705.84% |